Loading…

Are all antibiotic persisters created equal?

Antibiotic persisters are a sub-population of bacteria able to survive in the presence of bactericidal antibiotic despite the lack of heritable drug resistance mechanisms. This phenomenon exists across many bacterial species and is observed for many different antibiotics. Though these bacteria are o...

Full description

Saved in:
Bibliographic Details
Published in:Frontiers in cellular and infection microbiology 2022-08, Vol.12, p.933458-933458
Main Authors: Shultis, Michael W, Mulholland, Claire V, Berney, Michael
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c465t-c7ce02317b34b49c60ceee175ff021578263d90338a0a06f426a4d458155ef2b3
cites cdi_FETCH-LOGICAL-c465t-c7ce02317b34b49c60ceee175ff021578263d90338a0a06f426a4d458155ef2b3
container_end_page 933458
container_issue
container_start_page 933458
container_title Frontiers in cellular and infection microbiology
container_volume 12
creator Shultis, Michael W
Mulholland, Claire V
Berney, Michael
description Antibiotic persisters are a sub-population of bacteria able to survive in the presence of bactericidal antibiotic despite the lack of heritable drug resistance mechanisms. This phenomenon exists across many bacterial species and is observed for many different antibiotics. Though these bacteria are often described as "multidrug persisters" very few experiments have been carried out to determine the homogeneity of a persister population to different drugs. Further, there is much debate in the field as to the origins of a persister cell. Is it formed spontaneously? Does it form in response to stress? These questions are particularly pressing in the field of    , where persisters may play a crucial role in the required length of treatment and the development of multidrug resistant organisms. Here we aim to interpret the known mechanisms of antibiotic persistence and how they may relate to improving treatments for  , exposing the gaps in knowledge that prevent us from answering the question: Are all antibiotic persisters created equal?
doi_str_mv 10.3389/fcimb.2022.933458
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_f3bec105bd2e453c8eaaae02e64b2d86</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_f3bec105bd2e453c8eaaae02e64b2d86</doaj_id><sourcerecordid>2709911794</sourcerecordid><originalsourceid>FETCH-LOGICAL-c465t-c7ce02317b34b49c60ceee175ff021578263d90338a0a06f426a4d458155ef2b3</originalsourceid><addsrcrecordid>eNpVkU1PGzEQQK2qqESUH8Cl2mMPTbDHH2tfWiEEBQmpFzhbY-9sarTJBntTqf--DkkR8cG27Jk3M3qMXQi-kNK6yz6mVVgAB1g4KZW2H9gMQOo5OGs_vrufsvNSnnldLQfr5Cd2Kg03wrYwY9-uMjU4DA2upxTSOKXYbCiXVKa6NzETTtQ19LLF4cdndtLjUOj8cJ6xp9ubx-u7-cOvn_fXVw_zqIye5rGNxEGKNkgVlIuGRyISre57DkK3FozsHK9TIEduegUGVVcnEFpTD0Gesfs9txvx2W9yWmH-60dM_vVhzEuPuXY6kO9loCi4Dh2Q0jJaQsRanYwK0FlTWd_3rM02rKiLtJ4yDkfQ4591-u2X4x_vFFjjdoCvB0AeX7ZUJr9KJdIw4JrGbfHQcueEaJ2qoWIfGvNYSqb-rYzgfifNv0rzO2l-L63mfHnf31vGf0XyH7VykxI</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2709911794</pqid></control><display><type>article</type><title>Are all antibiotic persisters created equal?</title><source>PubMed Central (PMC)</source><creator>Shultis, Michael W ; Mulholland, Claire V ; Berney, Michael</creator><creatorcontrib>Shultis, Michael W ; Mulholland, Claire V ; Berney, Michael</creatorcontrib><description>Antibiotic persisters are a sub-population of bacteria able to survive in the presence of bactericidal antibiotic despite the lack of heritable drug resistance mechanisms. This phenomenon exists across many bacterial species and is observed for many different antibiotics. Though these bacteria are often described as "multidrug persisters" very few experiments have been carried out to determine the homogeneity of a persister population to different drugs. Further, there is much debate in the field as to the origins of a persister cell. Is it formed spontaneously? Does it form in response to stress? These questions are particularly pressing in the field of    , where persisters may play a crucial role in the required length of treatment and the development of multidrug resistant organisms. Here we aim to interpret the known mechanisms of antibiotic persistence and how they may relate to improving treatments for  , exposing the gaps in knowledge that prevent us from answering the question: Are all antibiotic persisters created equal?</description><identifier>ISSN: 2235-2988</identifier><identifier>EISSN: 2235-2988</identifier><identifier>DOI: 10.3389/fcimb.2022.933458</identifier><identifier>PMID: 36061872</identifier><language>eng</language><publisher>Switzerland: Frontiers Media S.A</publisher><subject>Anti-Bacterial Agents - pharmacology ; Anti-Bacterial Agents - therapeutic use ; Cellular and Infection Microbiology ; multidrug ; mycobacteria ; Mycobacterium tuberculosis - genetics ; persistence ; persister ; tolerance ; tuberculosis</subject><ispartof>Frontiers in cellular and infection microbiology, 2022-08, Vol.12, p.933458-933458</ispartof><rights>Copyright © 2022 Shultis, Mulholland and Berney.</rights><rights>Copyright © 2022 Shultis, Mulholland and Berney 2022 Shultis, Mulholland and Berney</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c465t-c7ce02317b34b49c60ceee175ff021578263d90338a0a06f426a4d458155ef2b3</citedby><cites>FETCH-LOGICAL-c465t-c7ce02317b34b49c60ceee175ff021578263d90338a0a06f426a4d458155ef2b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9428696/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9428696/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36061872$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Shultis, Michael W</creatorcontrib><creatorcontrib>Mulholland, Claire V</creatorcontrib><creatorcontrib>Berney, Michael</creatorcontrib><title>Are all antibiotic persisters created equal?</title><title>Frontiers in cellular and infection microbiology</title><addtitle>Front Cell Infect Microbiol</addtitle><description>Antibiotic persisters are a sub-population of bacteria able to survive in the presence of bactericidal antibiotic despite the lack of heritable drug resistance mechanisms. This phenomenon exists across many bacterial species and is observed for many different antibiotics. Though these bacteria are often described as "multidrug persisters" very few experiments have been carried out to determine the homogeneity of a persister population to different drugs. Further, there is much debate in the field as to the origins of a persister cell. Is it formed spontaneously? Does it form in response to stress? These questions are particularly pressing in the field of    , where persisters may play a crucial role in the required length of treatment and the development of multidrug resistant organisms. Here we aim to interpret the known mechanisms of antibiotic persistence and how they may relate to improving treatments for  , exposing the gaps in knowledge that prevent us from answering the question: Are all antibiotic persisters created equal?</description><subject>Anti-Bacterial Agents - pharmacology</subject><subject>Anti-Bacterial Agents - therapeutic use</subject><subject>Cellular and Infection Microbiology</subject><subject>multidrug</subject><subject>mycobacteria</subject><subject>Mycobacterium tuberculosis - genetics</subject><subject>persistence</subject><subject>persister</subject><subject>tolerance</subject><subject>tuberculosis</subject><issn>2235-2988</issn><issn>2235-2988</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNpVkU1PGzEQQK2qqESUH8Cl2mMPTbDHH2tfWiEEBQmpFzhbY-9sarTJBntTqf--DkkR8cG27Jk3M3qMXQi-kNK6yz6mVVgAB1g4KZW2H9gMQOo5OGs_vrufsvNSnnldLQfr5Cd2Kg03wrYwY9-uMjU4DA2upxTSOKXYbCiXVKa6NzETTtQ19LLF4cdndtLjUOj8cJ6xp9ubx-u7-cOvn_fXVw_zqIye5rGNxEGKNkgVlIuGRyISre57DkK3FozsHK9TIEduegUGVVcnEFpTD0Gesfs9txvx2W9yWmH-60dM_vVhzEuPuXY6kO9loCi4Dh2Q0jJaQsRanYwK0FlTWd_3rM02rKiLtJ4yDkfQ4591-u2X4x_vFFjjdoCvB0AeX7ZUJr9KJdIw4JrGbfHQcueEaJ2qoWIfGvNYSqb-rYzgfifNv0rzO2l-L63mfHnf31vGf0XyH7VykxI</recordid><startdate>20220817</startdate><enddate>20220817</enddate><creator>Shultis, Michael W</creator><creator>Mulholland, Claire V</creator><creator>Berney, Michael</creator><general>Frontiers Media S.A</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20220817</creationdate><title>Are all antibiotic persisters created equal?</title><author>Shultis, Michael W ; Mulholland, Claire V ; Berney, Michael</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c465t-c7ce02317b34b49c60ceee175ff021578263d90338a0a06f426a4d458155ef2b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Anti-Bacterial Agents - pharmacology</topic><topic>Anti-Bacterial Agents - therapeutic use</topic><topic>Cellular and Infection Microbiology</topic><topic>multidrug</topic><topic>mycobacteria</topic><topic>Mycobacterium tuberculosis - genetics</topic><topic>persistence</topic><topic>persister</topic><topic>tolerance</topic><topic>tuberculosis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Shultis, Michael W</creatorcontrib><creatorcontrib>Mulholland, Claire V</creatorcontrib><creatorcontrib>Berney, Michael</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Frontiers in cellular and infection microbiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Shultis, Michael W</au><au>Mulholland, Claire V</au><au>Berney, Michael</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Are all antibiotic persisters created equal?</atitle><jtitle>Frontiers in cellular and infection microbiology</jtitle><addtitle>Front Cell Infect Microbiol</addtitle><date>2022-08-17</date><risdate>2022</risdate><volume>12</volume><spage>933458</spage><epage>933458</epage><pages>933458-933458</pages><issn>2235-2988</issn><eissn>2235-2988</eissn><abstract>Antibiotic persisters are a sub-population of bacteria able to survive in the presence of bactericidal antibiotic despite the lack of heritable drug resistance mechanisms. This phenomenon exists across many bacterial species and is observed for many different antibiotics. Though these bacteria are often described as "multidrug persisters" very few experiments have been carried out to determine the homogeneity of a persister population to different drugs. Further, there is much debate in the field as to the origins of a persister cell. Is it formed spontaneously? Does it form in response to stress? These questions are particularly pressing in the field of    , where persisters may play a crucial role in the required length of treatment and the development of multidrug resistant organisms. Here we aim to interpret the known mechanisms of antibiotic persistence and how they may relate to improving treatments for  , exposing the gaps in knowledge that prevent us from answering the question: Are all antibiotic persisters created equal?</abstract><cop>Switzerland</cop><pub>Frontiers Media S.A</pub><pmid>36061872</pmid><doi>10.3389/fcimb.2022.933458</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2235-2988
ispartof Frontiers in cellular and infection microbiology, 2022-08, Vol.12, p.933458-933458
issn 2235-2988
2235-2988
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_f3bec105bd2e453c8eaaae02e64b2d86
source PubMed Central (PMC)
subjects Anti-Bacterial Agents - pharmacology
Anti-Bacterial Agents - therapeutic use
Cellular and Infection Microbiology
multidrug
mycobacteria
Mycobacterium tuberculosis - genetics
persistence
persister
tolerance
tuberculosis
title Are all antibiotic persisters created equal?
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T23%3A54%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Are%20all%20antibiotic%20persisters%20created%20equal?&rft.jtitle=Frontiers%20in%20cellular%20and%20infection%20microbiology&rft.au=Shultis,%20Michael%20W&rft.date=2022-08-17&rft.volume=12&rft.spage=933458&rft.epage=933458&rft.pages=933458-933458&rft.issn=2235-2988&rft.eissn=2235-2988&rft_id=info:doi/10.3389/fcimb.2022.933458&rft_dat=%3Cproquest_doaj_%3E2709911794%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c465t-c7ce02317b34b49c60ceee175ff021578263d90338a0a06f426a4d458155ef2b3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2709911794&rft_id=info:pmid/36061872&rfr_iscdi=true